OBJECTIVE: Atrophy of the corpus callosum is a recognized characteristic of multiple sclerosis (MS). We describe a new reliable method for measuring corpus callosum atrophy and correlate this with global cerebral atrophy measures. METHODS: Whole brain 3T MRI was performed in 38 relapsing-remitting MS subjects and 21 healthy controls (HC). Brain global gray and white matter volumes were segmented with SPM8. The contour of the corpus callosum was outlined on the midline of 3-D T1-weighted images by a semiautomated edge-detection technique to determine the corpus callosum area (CCA). Normalized CCA was correlated with other brain atrophy measures in MS subjects. RESULTS: CCA was disproportionately lower in MS subjects vs. HC (20.1% mean decrease; P < .001), with a large effect size (d = .62) when compared with global atrophy measures. In MS subjects, CCA correlated with brain parenchymal fraction (r = .55; P < .001) and gray matter fraction (r = .45; P = .005) but not white matter fraction (r = .18; P = .29). An inverse correlation with FLAIR hyperintense lesion volume (r = -.40; P = .01) was detected for CCA. CONCLUSION: Measurement of atrophy of the corpus callosum can have sensitivity as a useful imaging biomarker in patients with MS, even in patients with low disability levels. Both gray and white matter involvement in MS contribute to corpus callosum atrophy.
OBJECTIVE:Atrophy of the corpus callosum is a recognized characteristic of multiple sclerosis (MS). We describe a new reliable method for measuring corpus callosum atrophy and correlate this with global cerebral atrophy measures. METHODS: Whole brain 3T MRI was performed in 38 relapsing-remitting MS subjects and 21 healthy controls (HC). Brain global gray and white matter volumes were segmented with SPM8. The contour of the corpus callosum was outlined on the midline of 3-D T1-weighted images by a semiautomated edge-detection technique to determine the corpus callosum area (CCA). Normalized CCA was correlated with other brain atrophy measures in MS subjects. RESULTS:CCA was disproportionately lower in MS subjects vs. HC (20.1% mean decrease; P < .001), with a large effect size (d = .62) when compared with global atrophy measures. In MS subjects, CCA correlated with brain parenchymal fraction (r = .55; P < .001) and gray matter fraction (r = .45; P = .005) but not white matter fraction (r = .18; P = .29). An inverse correlation with FLAIR hyperintense lesion volume (r = -.40; P = .01) was detected for CCA. CONCLUSION: Measurement of atrophy of the corpus callosum can have sensitivity as a useful imaging biomarker in patients with MS, even in patients with low disability levels. Both gray and white matter involvement in MS contribute to corpus callosum atrophy.
Authors: Özgür Yaldizli; Iris-Katharina Penner; Karl Frontzek; Yvonne Naegelin; Michael Amann; Athina Papadopoulou; Till Sprenger; Jens Kuhle; Pasquale Calabrese; Ernst Wilhelm Radü; Ludwig Kappos; Achim Gass Journal: Mult Scler Date: 2013-08-19 Impact factor: 6.312
Authors: M K Houtchens; R H B Benedict; R Killiany; J Sharma; Z Jaisani; B Singh; B Weinstock-Guttman; C R G Guttmann; R Bakshi Journal: Neurology Date: 2007-09-18 Impact factor: 9.910
Authors: N L Sicotte; K C Kern; B S Giesser; A Arshanapalli; A Schultz; M Montag; H Wang; S Y Bookheimer Journal: Brain Date: 2008-04 Impact factor: 13.501
Authors: Andrew W Russo; Kirsten E Stockel; Sean M Tobyne; Chanon Ngamsombat; Kristina Brewer; Aapo Nummenmaa; Susie Y Huang; Eric C Klawiter Journal: Brain Struct Funct Date: 2022-05-10 Impact factor: 3.270
Authors: Sean M Tobyne; Daria Boratyn; Jessica A Johnson; Douglas N Greve; Caterina Mainero; Eric C Klawiter Journal: Hum Brain Mapp Date: 2016-05-24 Impact factor: 5.038
Authors: Elisa Dell'Oglio; Antonia Ceccarelli; Bonnie I Glanz; Brian C Healy; Shahamat Tauhid; Ashish Arora; Nikila Saravanan; Matthew J Bruha; Alexander V Vartanian; Sheena L Dupuy; Ralph H B Benedict; Rohit Bakshi; Mohit Neema Journal: J Neuroimaging Date: 2014-12-18 Impact factor: 2.486
Authors: Susie Y Huang; Qiuyun Fan; Natalya Machado; Ani Eloyan; John D Bireley; Andrew W Russo; Sean M Tobyne; Kevin R Patel; Kristina Brewer; Sarah F Rapaport; Aapo Nummenmaa; Thomas Witzel; Janet C Sherman; Lawrence L Wald; Eric C Klawiter Journal: Ann Clin Transl Neurol Date: 2019-03-30 Impact factor: 4.511
Authors: Marja Niiranen; Juha Koikkalainen; Jyrki Lötjönen; Tuomas Selander; Antti Cajanus; Päivi Hartikainen; Sakari Simula; Ritva Vanninen; Anne M Remes Journal: Brain Behav Date: 2022-06-28 Impact factor: 3.405